BioScrip Investors' Attys Win $2.7M In Fees From $11M Deal
By Dani Kass ( July 27, 2017, 6:58 PM EDT) -- A New York federal judge on Wednesday granted Bernstein Litowitz Berger & Grossman LLP's request for $2.7 million in attorneys' fees from BioScrip Inc. after getting the specialty pharmacy to pay shareholders $10.9 million for allegedly lying about fraud tied to Novartis AG's iron-reducing drug Exjade....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.